Organic compounds -- part of the class 532-570 series inventions 10/07

20070249848 - Yield improvement in the production of maleic anhydride: An improved process for the production of maleic anhydride by the catalytic oxidation of n-butane. Maleic anhydride is produced by reacting n-butane gas with oxygen or an oxygen-containing gas, in the presence of a vanadium phosphorus oxide (VPO) catalyst. An improved yield and selectivity in the production of maleic anhydride... Agent: Frank S. Digiglio Scully, Scott, Murphy & Presser, P.C.

20070249849 - Process: The present invention relates to a process for preparing a lactone. The process comprises the steps of reacting an aldehyde with an organic halide in a carbon chain extension reaction to form an alcohol compound comprising a functional group capable of allowing for carbonylation of said alcohol compound, and then... Agent: Frommer Lawrence & Haug

20070249850 - Dibenzylidene sorbitol (dbs)-based compounds, compositions and methods for using such compounds: The present invention relates to dibenzylidene sorbitol (“DBS”)-based compounds. The compounds of this invention are particularly advantageous in that they are characterized by one or more of improved transparency (reduced haze), reduced yellowing and/or improved organoleptics (taste). According to one embodiment, the present invention provides a disubstituted DBS-based compound having... Agent: Legal Department (m-495)

20070244332 - Reduction of acrylic acid in the production of maleic anhydride: An improved process for the production of maleic anhydride by the catalytic oxidation of n-butane. Maleic anhydride is produced by reacting n-butane gas with oxygen gas or an oxygen-containing gas, in the presence of a vanadium phosphorus oxide catalyst. A trialkyl phosphite or trialkyl phosphate component is continuously added to... Agent: Roberts & Roberts, L.L.P.

20070244333 - Method for preparing prostaglandin derivative:

20070244334 - Processes and intermediates for preparing steric compounds:

20070238883 - Process for the preparation of(s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, a duloxetine intermediate: Provided is a process for preparing a duloxetine intermediate, (S)-(+)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine (DNT), and its conversion to duloxetine or a pharmaceutically acceptable salt thereof.... Agent: Kenyon & Kenyon LLP

20070238884 - Fluorescent dyes and complexes: A fluorescent dye comprising a xanthene-derived fluorophore having the formula (I) wherein R1, R2, R3, R4, R5 and R6 are independently selected from H, alkyl, alkoxy, alcohol, ether, alkenyl, alkenoxy, aryl, alkaryl, aralkyl and amido, except that R1, R4 and/or R5 is not H when bonded to Y, Y1 or... Agent: Invitrogen Corporation C/o Intellevate

20070238885 - Method for the manufacture of lovastatin: A method for the manufacture of Lovastatin of formula (I) is disclosed. The method comprises of: A. lactonisation of Mevinolinic acid (II) and isolation of impure Lovastatin (I), B. purification of impure Lovastatin (I), C. optionally, repurification of pure Lovastatin (I) from a mixture of alumina and a water miscible... Agent: Ladas & Parry

20070238886 - Recovery of phytonutrients from oils: The present invention relates to an improved and integrated process for the extraction and purification of tocotrienols or tocopherols, carotenoids and sterols from vegetable and other edible oils. Fatty acids in the vegetable oils are subjected to alcoholic osterification to form ester-rich layer that includes fatty acid alkyl esters, carotenoids,... Agent: Meyer Unkovic & Scott LLP

20070238887 - Chemo-enzymatic process for the preparation of escitalopram: A process for preparing an intermediate for synthesizing escitalopram and the pharmaceutically acceptable salts thereof from 4-(4-dimethylamino)-1-(4′-fluorophenyl)-1-(hydroxybutyl)-3-(acyloxymethyl) benzonitrile is described. The process involves converting said intermediate into the (S+) enantiomer of citalopram by means of enzymatic enantiomeric resolution.... Agent: Perkins Coie LLP

20070238888 - Separation of propylene oxide from a mixture comprising propylene oxide and methanol: A method of separating propylene oxide from a mixture (M) comprising 5 to 50 percent by weight propylene oxide and 50 to 85 percent by weight methanol, said method comprising (i) introducing said mixture (M) into an extractive distillation column; (ii) additionally introducing a polar solvent into said extractive distillation... Agent: Oblon, Spivak, Mcclelland, Maier & Neustadt, P.C.

20070232813 - Substituted cyclohexadienals - syntheses and applications: The present invention is generally directed to the use of L-proline and certain derivatives thereof to catalyze the asymmetric self-condensation of α,β-unsaturated aldehydes to form homodimer and heterodimer cyclohexadienals. Reaction conditions are mild and yet amenable to a variety of different substrates yielding molecules with complex scaffolds from simple precursors.... Agent: Fulbright & Jaworski L.L.P.

20070232811 - Sterically hindered pi-bridge nonlinear optical chromophores, processes including same, and devices therefrom: In various embodiments, chromophores are described that include novel electron acceptors, novel electron donors, and/or novel conjugated bridges that are useful in nonlinear optical applications. In some embodiments, the present invention provides chromophore architectures wherein a chromophore contains more than one electron acceptor in electronic communication with a single electron... Agent: Fish & Richardson P.C.

20070232812 - Mono-, oligo- and polythieno [3,2-b]thiophenes: The invention relates to novel mono-, oligo- and polythieno[3,2-b]thiophenes, to their use as semiconductors or charge transport materials, in optical, electro-optical or electronic devices like for example liquid crystal displays, optical films, organic field effect transistors (FET or OFET) for thin film transistor liquid crystal displays and integrated circuit devices... Agent: Millen, White, Zelano & Branigan, P.C.

20070232814 - Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof: The present invention provides a novel polymorphic form of olopatadine hydrochloride ([(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride), a selective histamine H1-receptor antagonist that is used for the treatment of ocular symptoms of seasonal allergic conjunctivitis. The present invention also provides novel methods for producing olopatadine on a large scale, and in a manner... Agent: Scott B. Feder

20070232815 - Method for producing furan-2,5-dicarboxylic acid: A method for producing furan-2,5-dicarboxylic acid (FDCA) is provided which can efficiently and quantitatively producing FDCA under mild conditions, without employing an expensive catalyst and with a reduced energy consumption. A furan ring compound having two functional groups selected from a hydroxymethyl group, a formyl group and a carboxyl group... Agent: Fitzpatrick Cella Harper & Scinto